Substituted 1,1,1-trifluoro-3-[(benzyl)-(pyrimidin-2-yl)-amino]-propan-2-ol compounds, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
                            替代了1,1,1-三
氟-3-[(苄基)-(
嘧啶-2-基)-
氨基]-
丙醇化合物,含有这种化合物的制药组合物以及使用这种化合物来提高某些血浆脂质
水平,包括高密度脂蛋白
胆固醇,并降低某些其他血浆脂质
水平,如低密度脂蛋白
胆固醇和三酰
甘油,因此治疗由于高密度脂蛋白
胆固醇水平低和/或低密度脂蛋白
胆固醇和三酰
甘油水平高而加重的疾病,如动脉粥样硬化和心血管疾病在某些哺乳动物,包括人类中。